Case number 1:19-cv-01490
Par Pharmaceutical, Inc. et al v. American Regent, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 21, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the Consent Judgment filed in Lead Case No. 18-2032-CFC. (nmf) |
| May 7, 2020 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant American Regent, Inc.s Rule 26(a) Initial Disclosures and Defendant American Regents First Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by American Regent, Inc..(Stamoulis, Stamatios) |
| Apr 2, 2020 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rule 45 Subpoena to Eagle Pharmaceuticals, Inc. filed by American Regent, Inc..(Stamoulis, Stamatios) |
| Dec 16, 2019 | 24 | Motion for Miscellaneous Relief (3) Docket Text: MOTION Defendants' Motion for Claim Construction - filed by Amphastar Pharmaceuticals, Inc.. (Phillips, John) |
| Oct 1, 2019 | 23 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 10/11/2019 at 11:30 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 10/1/19. Associated Cases: 1:18-cv-02032-CFC, 1:19-cv-00712-CFC, 1:19-cv-01490-CFC(cak) |
| Sep 27, 2019 | 22 | SO ORDERED (4) Docket Text: SO ORDERED, re (31 in 1:19-cv-00712-CFC, 44 in 1:18-cv-02032-CFC, 20 in 1:19-cv-01490-CFC) STIPULATION and ORDER OF Consolidation. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-2032-CFC ONLY. Signed by Judge Colm F. Connolly on 9/26/2019. Associated Cases: 1:18-cv-02032-CFC, 1:19-cv-00712-CFC, 1:19-cv-01490-CFC(nmf) |
| Sep 27, 2019 | 21 | Protective Order (18) Docket Text: PROTECTIVE ORDER Signed by Judge Colm F. Connolly on 9/26/2019. Associated Cases: 1:18-cv-02032-CFC, 1:19-cv-00712-CFC, 1:19-cv-01490-CFC(nmf) |
| Sep 27, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-02032-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:18-cv-02032-CFC ONLY. (nmf) |
| Sep 25, 2019 | 20 | Exhibit A (19) |
| Sep 25, 2019 | 20 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order for Consolidation by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Farnan, Brian) |
| Sep 25, 2019 | 20 | Exhibit B (12) |
| Sep 23, 2019 | 19 | Notice (Other) (2) Docket Text: NOTICE of Appearance of Joseph J. Gribbin by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC (Farnan, Brian) |
| Sep 20, 2019 | 18 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Endo International PLC for Par Pharmaceutical, Inc.; Corporate Parent Par Pharmaceutical, Inc. for Endo Par Innovation Company, LLC; Other Affiliate Par Pharmaceutical, Inc. for Par Sterile Products, LLC filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Farnan, Brian) |
| Sep 17, 2019 | 17 | Answer to Counterclaim (11) Docket Text: ANSWER to [10] Answer to Complaint,, Counterclaim, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Farnan, Brian) |
| Sep 16, 2019 | 16 | Redacted Document (30) Docket Text: REDACTED VERSION of [10] Answer to Complaint,, Counterclaim, by American Regent, Inc.. (Stamoulis, Stamatios) |
| Sep 16, 2019 | 15 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1)(A) and (ii) Plaintiffs' Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Farnan, Brian) |
| Sep 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Robert D. Rhoad for Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Sep 13, 2019 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant American Regent Inc.s Rule 26(a) Initial Disclosures and Defendants Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by American Regent, Inc..(Stamoulis, Stamatios) |
| Sep 6, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Sharon K. Gagliardi for Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., and Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Sep 6, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi and Robert D. Rhoad filed by Endo Par Innovation Company, LLC, Par Sterile Products, LLC, Par Pharmaceutical, Inc. Signed by Judge Colm F. Connolly on 9/6/2019. (fms) |
| Sep 6, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Uma N. Everett for American Regent, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Sep 5, 2019 | 13 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi and Robert D. Rhoad - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Farnan, Brian) |
| Sep 4, 2019 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo, Inc., Corporate Parent Daiichi Sankyo U.S. Holdings, Inc., Corporate Parent Baiichi Sankyo Company, Limited for American Regent, Inc. filed by American Regent, Inc.. (Stamoulis, Stamatios) |
| Sep 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Dennies Varughese for American Regent, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Sep 4, 2019 | 12 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,478 B1 ;9,687,526 B2 ;9,744,209 B2 ;9,750,785 B2 ;9,744,239 B2 . (Stamoulis, Stamatios) |
| Sep 3, 2019 | N/A | Remark (0) Docket Text: NOTICE TO COUNSEL Stamatios Stamoulis, Esq.: The Patent/Trademark Report and Rule 7.1 Disclosure Statement filed as attachments to the Answer and Counterclaim at D.I. [10] should be docketed separately using the appropriate docket codes found under OTHER FILINGS, OTHER DOCUMENTS. (fms) |
| Aug 30, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles T. Wysocki for American Regent, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 28, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Uma N. Everett filed by American Regent, Inc. Signed by Judge Colm F. Connolly on 8/28/2019. (fms) |
| Aug 28, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 8/28/2019. (Court Reporter S. Ingraham, Hawkins Reporting.) Counsel to submit the final revised scheduling order to the Court. Associated Cases: 1:18-cv-02032-CFC, 1:19-cv-00712-CFC, 1:19-cv-01490-CFC(nmf) |
| Aug 27, 2019 | 9 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Uma N. Everett - filed by American Regent, Inc.. (Stamoulis, Stamatios) |
| Aug 27, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (6 in 1:19-cv-01490-CFC, 39 in 1:18-cv-02032-CFC, 27 in 1:19-cv-00712-CFC) Letter. A Telephone Scheduling Conference is set for 8/28/2019 at 11:00 AM before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 8/27/2019. Associated Cases: 1:19-cv-01490-CFC, 1:18-cv-02032-CFC, 1:19-cv-00712-CFC(fms) |
| Aug 27, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Dennies Varguhese and Charles Wysocki filed by American Regent, Inc. Signed by Judge Colm F. Connolly on 8/27/2019. (fms) |
| Aug 26, 2019 | 8 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dennies Varguhese and Charles Wysocki - filed by American Regent, Inc.. (Stamoulis, Stamatios) |
| Aug 26, 2019 | 7 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Stamatios Stamoulis on behalf of American Regent, Inc. (Stamoulis, Stamatios) |
| Aug 26, 2019 | 6 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Brian E. Farnan regarding August 28, 2019 Scheduling Conference. (Farnan, Brian) |
| Aug 22, 2019 | 5 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Par Sterile Products, LLC, Par Pharmaceutical, Inc., Endo Par Innovation Company, LLC. American Regent, Inc. served on 8/15/2019, answer due 9/5/2019. (Farnan, Brian) |
| Aug 14, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmg) |
| Aug 9, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to American Regent, Inc. on 8/9/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (kmd) |
| Aug 9, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,375,478 B1; US 9,687,526 B2; US 9,744,209 B2; US 9,750,785 B2. (kmd) |
| Aug 9, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/28/2019. Date of Expiration of Patent: 1/30/2035.Thirty Month Stay Deadline: 12/28/2021. (kmd) |
| Aug 9, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Aug 9, 2019 | 1 | Civil Cover Sheet (1) |
| Aug 9, 2019 | 1 | Exhibit D (83) |
| Aug 9, 2019 | 1 | Exhibit C (84) |
| Aug 9, 2019 | 1 | Exhibit B (80) |
| Aug 9, 2019 | 1 | Exhibit A (33) |
| Aug 9, 2019 | 1 | Complaint* (1) |
